-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...

Acadia Pharmaceuticals Inc. is downgraded from Buy to Hold following the failure of its carbetocin (ACP-101) program for Prader-Willi Syndrome. Despite the setback, ACAD remains positioned for growth ...

SINGAPORE - The Singapore Civil Defence Force (SCDF) will sound an “Important Message” signal through the islandwide Public Warning System (PWS) on Sept 15, at 6.20pm. SCDF on its website advised the ...

Hospitalization was frequent, though lengths of stay varied, and polypharmacy was common among individuals with PWS. Prader-Willi syndrome (PWS) imposes a profound, multifaceted burden on patients, ...

The PADQ addresses a critical gap, as traditional anxiety assessments are often unsuitable for people with PWS due to cognitive impairments and unique behavioral triggers. Anxiousness- and ...

(RTTNews) - Aardvark Therapeutics, Inc. (AARD) announced Tuesday its participation in the 2025 United in Hope Conference for Prader-Willi syndrome or PWS on June 24-28 in Phoenix, Arizona. The company ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. As a rare complex genetic ...

MANILA, Philippines — Prime Integrated Waste Solutions (PWS), a subsidiary of Enrique Razon Jr.’s Prime Infrastructure Capital Inc., has launched the commercial sale of verified plastic credits, a ...

Prader-Willi syndrome (PWS) is a rare, complicated condition that affects many parts of your body. It stems from a problem with one of your chromosomes (a strand of DNA that carries your genes). It ...

REDWOOD CITY, Calif. - Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company with a market capitalization of $3.08 billion, announced today the U.S. commercial availability of VYKAT XR ...

Meridian-based Scentsy, the maker of wickless candles and other scented products, is conducting a second wave of layoffs. The company said in a news release that it is laying off 116 people, which it ...